Read news on Trial results with our app.
Read more in the app
ESMO 2025: Trial results show belzutifan shrinks rare neuroendocrine tumors and improves symptoms in patients - EurekAlert!
Trial results for new lung cancer drug are ‘off the charts’, say doctors | Lung cancer
